Research Library
Structure Unavailable
Verified structure not on file
Medicine

Atorvastatin

HMG-CoA reductase inhibitor; lipid-lowering statin

Mechanism of Action

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol biosynthesis (mevalonate pathway). By inhibiting HMG-CoA reductase, atorvastatin reduces intracellular cholesterol, upregulating LDL receptor expression and increasing hepatic LDL clearance from circulation. Beyond LDL reduction, atorvastatin has pleiotropic effects: improved endothelial function, reduced inflammation (lowered CRP), decreased oxidative stress, and plaque stabilization. It is metabolized by CYP3A4 and has a long duration of action due to active metabolites.

Evidence Chain

Atorvastatin

COMPOUND

1 Research Goal

• Anti-Aging & Longevity

Evidence Strength

Clinical Trial

6 articles sourced

Knowledge Graph

(7 connections)
CompoundGoalArticleArticleArticle
Compound (Center)
Research Goal
Linked Article

Research Evidence

(6)

Clomiphene Citrate: Evidence-Based Research Review

6 min

Clomiphene citrate (CC) is a non-steroidal triphenylethylene derivative classified as a Selective Estrogen Receptor Modulator (SERM). Originally developed for the induction of ovulation in women with anovulatory infertility, it has become a cornerstone of reproductive medicine. CC operates as a race

Clinical Trial

Testosterone Enanthate: Evidence-Based Research Review

6 min

Testosterone enanthate (TE) is a long-acting esterified formulation of the primary endogenous androgen, testosterone. Since its clinical introduction in the 1950s, it has served as a cornerstone for testosterone replacement therapy (TRT) in male hypogonadism and a reference compound in clinical rese

Clinical Trial

Raloxifene: Evidence-Based Research Review

6 min

Raloxifene is a second-generation selective estrogen receptor modulator (SERM) of the benzothiophene class. Developed to address the limitations of first-generation SERMs like tamoxifen, raloxifene exhibits distinct tissue-specific effects: it acts as an estrogen receptor (ER) agonist in bone and li

Clinical Trial

BPC-157 and Tissue Repair Signaling Pathways

9 min

Comprehensive review of BPC-157 mechanisms in tissue repair, angiogenesis, and mucosal healing.

Clinical Trial

Boldenone Undecylenate: Evidence-Based Research Review

6 min

Boldenone undecylenate, a synthetic derivative of testosterone originally developed for veterinary use, is a long-acting injectable anabolic-androgenic steroid (AAS). Characterized by a double bond between the C1 and C2 positions, the compound exhibits a favorable ratio of anabolic to androgenic act

Preclinical

Trenbolone Acetate: Evidence-Based Research Review

6 min

Trenbolone acetate (TBA) is a potent synthetic 19-nortestosterone derivative classified as an anabolic-androgenic steroid (AAS). Originally developed for veterinary applications—specifically to increase muscle mass and feed efficiency in beef cattle—TBA has become a focal point of pharmacological in

Preclinical

Synergy & Compatibility

(5)

Computational assessment of bio-regulatory compatibility with compounds sharing research goals. Scores reflect half-life alignment, receptor target overlap, and bioavailability data.

Highest Compatibility

Atorvastatin + Cardarine (GW-501516)

High Compatibility

80%
View full comparison matrix

Computational assessment based on available pharmacology data. Does not account for individual variability, dose-dependent effects, or unstudied interactions. For research use only.

Community Observations

(0)

Qualitative, self-reported researcher observations. Distinct from peer-reviewed evidence — not medical advice.

No approved observations yet. Sign in to contribute.

Research Use Only

For research use only. Not medical advice.

ARIA · Sign in to chat